BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Generic Pharmaceutical Association (GPhA) Hosts Telephonic Media Briefing To Unveil A New Study Refuting PhRMA Conclusions About Consumer Benefits Of Authorized Generics


7/28/2006 1:37:15 PM

ARLINGTON, Va., July 28 /PRNewswire/ -- The Generic Pharmaceutical Association (GPhA) today said it will hold a telephonic media briefing on Monday, July 31, beginning at 10:00 AM, to unveil an analysis that conclusively demonstrates that the anti-competitive brand pharmaceutical practice of introducing authorized generics (AGs) "significantly reduces incentives for independent generic firms to challenge invalid brand name patents and to develop non-infringing processes and provide no consumer savings."

Representatives of the GPhA and the study's authors will present the findings on the conference call and respond to media questions. The number to call to participate in the briefing is: 800-311-9407 and the passcode is GPHA.REPORT.

GPhA's independent analysis raises serious questions about the validity of the recent PhRMA study on authorized generics, noting that factors such as an inconsistent choice of data, inadequate data points and the use of wholesale instead of retail prices resulted in "significant problems" and that the errors create great concerns regarding the utility of the conclusions provided by it.

GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk active pharmaceutical chemicals, and suppliers of other goods and services to the generic drug industry. Generics represent 56% of the total prescriptions dispensed in the United States, but less than 13.1% of all dollars spent on prescription drugs. For more information about the industry, visit www.gphaonline.org.

Generic Pharmaceutical Association

CONTACT: Andrea Hofelich, +1-703-647-2495, for GPhA



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES